Awardee OrganizationWAKE FOREST UNIVERSITY HEALTH SCIENCES
Description
Abstract Text
DESCRIPTION (provided by applicant): The goal of this project is to determine how the immune response to Listeria monocytogenes is regulated by activation of antigen presenting cells. Listeria trigger APC activation through a network of pattern recognition receptors and signaling adapters. Signals transduced upon cytoplasmic entry are required for virulence of the bacteria and for development of protective immunity. Likewise, signaling through the Toll-like receptor adapter MyD88 is essential for a significant portion of the DC maturation response induced by listerial infection. We have identified many of the key molecules induced in DC by listerial cytoplasmic entry. We determined that the expression of costimulatory molecules and inflammatory cytokines by DC was dependent upon expression of the hemolysin, LLO and bacterial cytoplasmic entry. We have also determined the role of each of these molecules in priming CD8+ T cell proliferation and function. We will now explore the molecular basis for DC maturation induced by Listeria by examining the role of Toll-like receptors, TLR adapters, and cytosolic receptors with the studies proposed in Specific Aim 1. We will also determine the role of these molecules in generating protective immunity to Listeria using Listeria-infected DC as an immunogen in vivo. We will then determine the role of costimulatory molecules and cytokines induced by listerial infection in the formation of the immunological synapse with the studies proposed in specific aim 2. These novel studies will reveal how the interaction of T cells with infected antigen presenting cells gives rise to protective T cell responses. Our studies will provide important insights into the interaction of this intracellular bacteria with the host immune system and will aid the design of efficacious vaccines against this pathogen.
National Institute of Allergy and Infectious Diseases
CFDA Code
856
DUNS Number
937727907
UEI
SN7KD2UK7GC5
Project Start Date
15-February-2005
Project End Date
31-January-2010
Budget Start Date
01-February-2007
Budget End Date
31-January-2008
Project Funding Information for 2007
Total Funding
$340,160
Direct Costs
$237,045
Indirect Costs
$103,115
Year
Funding IC
FY Total Cost by IC
2007
National Institute of Allergy and Infectious Diseases
$340,160
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5R01AI057770-03
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5R01AI057770-03
Patents
No Patents information available for 5R01AI057770-03
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5R01AI057770-03
Clinical Studies
No Clinical Studies information available for 5R01AI057770-03
News and More
Related News Releases
No news release information available for 5R01AI057770-03
History
No Historical information available for 5R01AI057770-03
Similar Projects
No Similar Projects information available for 5R01AI057770-03